Arş. Gör. Dr. OZAN KAPLAN

Yayın Ağı

Makaleler 36

1. Metabolomic Profiling Reveals Distinct Signatures in Primary and Secondary Polycythemia

Yildirim M., Erdogdu B., Sayin S., KAPLAN O., Koc E., Karadeniz M., et al.

METABOLITES , cilt.15, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Hepatic Metabolic Dysregulation as a Potential Amplifier of Leukemogenesis Following mRNA Vaccination: A Novel Mechanistic Hypothesis

Erdogdu B., KAPLAN O., ÇELEBİER M., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.

MEDICINA-LITHUANIA , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

3. Assessment of Children's Exposure Levels to Organophosphate Flame Retardants: A Human Biomonitoring Study in Ankara, Turkey

İYİGÜNDOĞDU İ., KAPLAN O., Gunay F., ÇELEBİER M., ULUKOL B., ÇOK İ.

TOXICOLOGY LETTERS , cilt.411, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Do Preparation Techniques Transform the Metabolite Profile of Platelet-Rich Plasma?

Fidan B. B., Koc E., Ozotuk E. C., KAPLAN O., ÇELEBİER M., KORKUSUZ F.

BIOENGINEERING-BASEL , cilt.12, sa.7, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Promising Antimycobacterial Agents: Salicylidenehydrazines

ÜNSAL TAN O., Vagolu S. K., Tonjum T., KAPLAN O., ŞİMŞEK R.

ARCHIV DER PHARMAZIE , cilt.358, sa.7, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine Administration

Erdogdu B., KAPLAN O., Fidan B. B., ÇELEBİER M., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.

CURRENT MOLECULAR MEDICINE , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Metabolomic Profiling and Bioanalysis of Chronic Myeloid Leukemia: Identifying Biomarkers for Treatment Response and Disease Monitoring

Sayin S., Yildirim M., Erdogdu B., KAPLAN O., Koc E., Bulduk T., et al.

METABOLITES , cilt.15, sa.6, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. Metabolomic Profiling Reveals Distinct Pathways in Degenerated and Non-degenerated Rotator Cuff Tears: Implications for Pathogenesis and Treatment

Bulbul F., Koc E., Fidan B. B., KAPLAN O., Ruzgar H., BİLGE O., et al.

CURRENT MOLECULAR MEDICINE , 2025 (SCI-Expanded, Scopus)

9. Donor tissue type alters the effects of mesenchymal stem cells on human osteoarthritic chondrocytes and their metabolomic profiles

KARAÇOBAN L., Gizer M., Fidan B. B., KAPLAN O., ÇELEBİER M., Korkusuz P., et al.

RESEARCH IN SPORTS MEDICINE , 2025 (SCI-Expanded, Scopus)

10. Altered plasma levels of arachidonic acid, choline, amino acids, and sphingolipids signal neural tube defects Altered plasma metabolite profiles associated with neural tube defects

Ozel S., KAPLAN O., Fidan B. B., ÇELEBİER M., Engin-Ustun Y.

AIMS MOLECULAR SCIENCE , sa.1, ss.99-112, 2025 (ESCI)

11. Metabolomic signature in ocular dosing: Exploring the metabolic impacts of sublethal high-dose naringenin on ARPE-19 cells

KAPLAN O., Koc E., TÜRK S., Kucukkilinc T. T., GÖKTAŞ Z., ÇELEBİER M.

EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , cilt.72, 2024 (SCI-Expanded, Scopus)

12. A Facile and Efficient Protocol for Phospholipid Enrichment in Synovial Joint Fluid: Monodisperse-Mesoporous SiO₂ Microspheres as a New Metal Oxide Affinity Sorbent

Aladag S., Demirdis I., GÖKÇAL KAPUCU B., Koc E., KAPLAN O., AKTAŞ B. E., et al.

SEPARATIONS , cilt.11, sa.9, 2024 (SCI-Expanded, Scopus)

13. A Comprehensive Examination of UV-VIS Spectrophotometric Methods in Pharmaceutical Analysis Between 2015-2023

Enes D., Dastan K., KAPLAN O., ÇELEBİER M., DOĞAN A.

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING , sa.7, ss.1125-1132, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. An Isolated Perfused Rat Liver Model: Simultaneous LC-MS Quantification of Pitavastatin, Coproporphyrin I, and Coproporphyrin III Levels in the Rat Liver and Bile

İZAT N., KAPLAN O., ÇELEBİER M., ŞAHİN S.

ACS OMEGA , cilt.9, sa.17, ss.19250-19260, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Development and UV-VIS Spectrophotometric analysis of an ease-of-use pediatric oral solution of dexamethasone for personalized therapies

Enes D., Fidan B. B., KAPLAN O., DOĞAN A., Altinoz S., ÇELEBİER M., et al.

JOURNAL OF RESEARCH IN PHARMACY , cilt.28, sa.5, ss.1791-1799, 2024 (ESCI, Scopus, TRDizin)

16. Plasma metabolomics for diagnostic biomarkers on ectopic pregnancy

KAPLAN O., Ertürk Aksakal S., Fidan B. B., Engin-Üstün Y., ÇELEBİER M.

Scandinavian Journal of Clinical and Laboratory Investigation , cilt.84, sa.1, ss.44-52, 2024 (SCI-Expanded, Scopus)

17. RP-HPLC method combined with ultrafiltration for simultaneous analysis of Melphalan and Topotecan in human plasma samples

KAPLAN O., Yilmaz N., UÇAR B., ALGEDİK TOKYÜREK M. Ö., KOÇ İ., KIRATLI H., et al.

JOURNAL OF CHEMICAL METROLOGY , cilt.18, ss.30-40, 2024 (ESCI, Scopus)

18. Development of an RP-HPLC method to evaluate the basic characteristics of talazoparib-loaded PLGA nanoparticles

Topcu B. T., KAPLAN O., Pehlivan S. B., ÇELEBİER M., ÖNER L.

JOURNAL OF CHEMICAL METROLOGY , cilt.18, ss.10-18, 2024 (ESCI, Scopus)

19. A Plant Metabolomic Approach to Identify the Difference of the Seeds and Flowers Extracts of Carthamus tinctorius L.

KAPLAN O., SALTAN N., Köse A., KÖSE Y. B., ÇELEBİER M.

Mass Spectrometry Letters , cilt.14, sa.2, ss.42-47, 2023 (ESCI, Scopus)

20. Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension

Ongun M. C., Tonyali N. V., KAPLAN O., DEĞER İ., ÇELEBİER M., BAŞCI AKDUMAN N. E., et al.

Placenta , cilt.137, ss.88-95, 2023 (SCI-Expanded, Scopus)

21. Pharmacometabolomic assessment of vitamin E loaded human serum albumin nanoparticles on HepG2 cancer cell lines

Şenol Y., KAPLAN O., VARAN C., Demirtürk N., Öncül S., Fidan B. B., et al.

Journal of Drug Delivery Science and Technology , cilt.79, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

22. Plasma irisin and metabolomic response differ between concentric and isometric exercise Effets différents de l'exercice concentrique et de l'exercice isométrique sur l'irisine plasmatique et la réponse métabolomique

KARA Ö. S., ERCAN A., ÇELEBİER M., KAPLAN O., ÖNCÜL S., KORKUSUZ F.

Science and Sports , cilt.37, sa.7, ss.610-617, 2022 (SCI-Expanded, Scopus)

23. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients

Solmaz İ., KAPLAN O., ÇELEBİER M., LAY İ., Anlar B.

Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.1299-1310, 2022 (SCI-Expanded, Scopus, TRDizin)

24. Q-tof lc/ms-based untargeted metabolomics approach to evaluate the effect of folate-conjugated cyclodextrins on triple-negative breast cancer cells

Varol I., KAPLAN O., Erdoğar N., Öncül S., Nielsen T. T., ERCAN A., et al.

Current Pharmaceutical Analysis , cilt.17, sa.10, ss.1272-1281, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Comparison of Different Sample Preparation Techniques for Untargeted Metabolomics Utilizing Q-TOF LC/MS and MetaboAnalyst 4.0

Kaplan O., Koçak E., Çelebier M.

Current Metabolomics and Systems Biology , cilt.8, ss.53-60, 2021 (Hakemli Dergi)

26. Bioanalytical Method Validation of an RP-HPLC Method for Determina-tion of Rifampicin in Liver Perfusion Studies

İZAT N., KAPLAN O., ÇELEBİER M., ŞAHİN S.

CURRENT PHARMACEUTICAL ANALYSIS , cilt.17, sa.7, ss.919-925, 2021 (SCI-Expanded, Scopus)

27. UPLC-Q-TOF/MS based Untargeted Metabolite and Lipid Analysis on Premature Ovarian Insufficiency Plasma Samples

Tasci Y., Findik R. B., Pekcan M. K., KAPLAN O., ÇELEBİER M.

CURRENT PHARMACEUTICAL ANALYSIS , cilt.17, sa.4, ss.474-483, 2021 (SCI-Expanded, Scopus)

28. Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis

DEMİR S., KAPLAN O., ÇELEBİER M., SAĞ E., BİLGİNER Y., LAY İ., et al.

Seminars in Arthritis and Rheumatism , cilt.50, sa.6, ss.1238-1244, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Polycystic ovary syndrome in adolescents: Q-TOF LC/MS analysis of human plasma metabolome

ÇELEBİER M., KAPLAN O., Özel Ş., Engin-Üstün Y.

Journal of Pharmaceutical and Biomedical Analysis , cilt.191, 2020 (SCI-Expanded, Scopus)

30. Evaluation of Recent Data Processing Strategies on Q-TOF LC/MS Based Untargeted Metabolomics

KAPLAN O., ÇELEBİER M.

MASS SPECTROMETRY LETTERS , cilt.11, sa.1, ss.1-5, 2020 (ESCI, Scopus)

31. Past, present and future of metabolomic studies Metabolomik çalışmaların dünü, bugünü ve yarını

KAPLAN O., ÇELEBİER M.

Turkiye Klinikleri Journal of Medical Sciences , cilt.40, sa.3, ss.366-374, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

32. Liquid-liquid extraction and ultrafiltration based sample preparation technique for Q-TOF LC/MS analysis of non-polar metabolites in human plasma samples

KOÇAK E., KAPLAN O., ÇELEBİER M.

Journal of Research in Pharmacy , cilt.24, sa.1, ss.38-43, 2020 (ESCI, Scopus, TRDizin)

33. Comparison of cell lysis techniques via q-tof lc/ms

KAPLAN O., ÖNCÜL S., ERCAN A., ÇELEBİER M.

Mass Spectrometry Letters , cilt.11, sa.2, ss.36-40, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma

34. Discovery of Michael acceptor containing 1,4-dihydropyridines as first covalent inhibitors of L-/T-type calcium channels

Cevher H. A., Schaller D., Gandini M. A., KAPLAN O., Gambeta E., Zhang F. X., et al.

BIOORGANIC CHEMISTRY , cilt.91, 2019 (SCI-Expanded, Scopus)

35. Determination of the physicochemical properties of piroxicam

ÇELEBİER M., NENNİ M., KAPLAN O., AKGEYİK E., KAYNAK M. S., ŞAHİN S.

TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.0, sa.0, 2019 (Scopus, TRDizin)

36. Global omics strategies to investigate the effect of cyclodextrin nanoparticles on MCF-7 breast cancer cells

ERCAN A., ÇELEBİER M., VARAN G., ÖNCÜL S., Nenni M., KAPLAN O., et al.

European Journal of Pharmaceutical Sciences , cilt.123, ss.377-386, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 11

1. UNTARGETED METABOLOMICS APPROACH FOR ACUTE PANCREATITIS: SEARCHING FOR POTENTIAL MARKERS USING UPLC-Q-TOF-MS

TURAN GÖKÇE D., ÇELEBİER M., KAPLAN O., Ari D., Fidan B. B., Ors E., et al.

Digestive Disease Week (DDW), Illinois, Amerika Birleşik Devletleri, 6 - 09 Mayıs 2023, cilt.164, (Özet Bildiri)

2. Validation of an HPLC method for the determination of talazoparib from nanoparticle formulations

Taş B., Akdağ Çaylı Y., Aytekin E., Pehlivan S., Öner L., Kaplan O.

3rd International Gazi Pharma Symposium Series (GPSS-2021), 8 - 10 Eylül 2021, ss.1-2, (Özet Bildiri)

3. AN INNOVATIVE SAMPLE PREPARATION TECHNIQUE TO EVALUATE THE DIFFERENCES IN METABOLOME LEVELS FOR SYNOVIA AND FAT TISSUES

KARAÇOBAN L., KAPLAN O., MENDERES Y., ÇELEBİER M., KORKUSUZ F.

European Orthopaedic Research Society 28th Annual Meeting Congress, İzmir, Türkiye, 17 - 18 Eylül 2020, (Özet Bildiri)

4. Bioanalytical Validation of an HPLC Method for the Analysis of Rifampicin Accumulation in Rat Liver

İzat N., Kir F., Kaplan O., Çelebier M., Şahin S.

8. BBBB International Conference on Pharmaceutical Sciences (8.BBBB 2019), İzmir, Türkiye, 14 - 16 Ekim 2019, ss.332-333, (Özet Bildiri)

5. Comparison of different sample preparation techniques on human plasma samples for Q-TOF LC/MS based metabolite profiling

ÇELEBİER M., KAPLAN O., KOÇAK E.

Euroanalysis 2019, İstanbul, Türkiye, 1 - 05 Temmuz 2019, (Tam Metin Bildiri)

6. Comparison of Metabolite Extraction Techniques for LC/MS Based Metabolomics on Human Blood Plasma

KAPLAN O., KOÇAK E., ÇELEBİER M.

International Multisciplinary Symposium on Drug Research Development - DRD 2019, Malatya, Türkiye, 1 - 03 Temmuz 2019, (Tam Metin Bildiri)

7. Is It Possible To Use Pooled Plasma Samples For Large-Scale Human Metabolomic Studies? A Comparison Of The Metabolite Profiles Of Pooled Plasma Samples With Random Individual Samples Using Q-TOF LC/MS

ÇELEBİER M., KAPLAN O., OZEL Ş., ÜSTÜN Y., KOÇAK E.

1st International Congress on Analytical and Bioanalytical Chemistry, Antalya, Türkiye, 27 - 30 Mart 2019, (Tam Metin Bildiri)

8. Evaluation of Antimicrobial Effect of Simvastatin on E. coli with Metabolomics Analysis

KOÇAK E., ÖZKUL KOÇAK C., KAPLAN O., ÇELEBİER M., NEMUTLU E., KIR S., et al.

1st International Congress on Analytical and Bioanalytical Chemistry, Antalya, Türkiye, 27 Mart 2019, (Tam Metin Bildiri)

9. A Metabolomic Study to Investigate the Effect of Folate Conjugated Nanoparticles on Triple Negative Breast Cancer Cells

ERCAN A., ÇELEBİER M., varol ı., KAPLAN O., Varan G., ÖNCÜL S., et al.

EUFEPS Annual Meeting 2019 PERSONALIZED MEDICINES,TARGETED THERAPIES,PRECISION DRUG DELIVERY, 6 - 08 Mart 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

10. The effect of polycationic amphiphilic cyclodestrin nanoparticles on mda-mb cancer cells: A metabolomic approach to understand the mechanism

ÇELEBİER M., KAPLAN O., VARAN G., ÖNCÜL S., KOÇAK E., ERCAN A., et al.

12 th International symposium on pharmaceutical sciences, 26 Haziran 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

11. GENOMIC AND METABOLOMIC STUDIES OF POLYCATIONIC AMPHIPHILIC CYCLODEXTRIN NANOPARTICLESON HEPG2 CELL LINE

ERCAN A., ÇELEBİER M., Varan G., ÖNCÜL S., KOÇAK E., KAPLAN O., et al.

EUFEPS Annual Meeting 2018 Crossing Barriers for Future Medicines, 24 - 26 Mayıs 2018, (Tam Metin Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler